SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tom Allinder who wrote (28361)2/16/2000 5:03:00 PM
From: Dave Gore  Read Replies (1) of 150070
 
Tom, not to mislead anyone, ADVR is about to submit an IND app (new drug application) to the FDA. According to Jill it will take sometime to get approved (she wouldn't even guess) and if they do approve it, which they very possibly will, then the human clinical trials will start in the U.S.

The good news is that they have already done some human trials apparently outside the U.S., but the new drug app they are submitting to the FDA is a first step to trials here in the U.S.

Good company from what I can tell, but there is still some waiting involved. For long term holders, could be quite lucrative if all works out.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News